Latest Annual Report
Filed: 2026-03-31
Key Insights
- Tharimmune, Inc. (CNTN) appears to be actively raising capital through various financing arrangements, including a private placement, PIPE offerings, and a direct public offering in 2025.
- The company has entered into an At-The-Market (ATM) agreement, which provides additional flexibility to raise funds as needed.
- Tharimmune has issued a significant number of warrants and options, which could lead to future dilution for shareholders if exercised.